CONTROL OF BREATHING IN DISEASE STATES
Disordered respiratory control usually accompanies other states and rarely in itself constitutes an independent clinical disorder.
Chronic Obstructive Pulmonary Disease (COPD). Patients with physiologically significant COPD have a reduced ventilatory response to hypoxia and hypercapnia. While this was formerly thought to be entirely due to decreased chemosensitivity of the respiratory centers, most of these patients display an increased resting respiratory center drive. In hypercapnic patients this heightened respiratory drive fails to translate into a sufficiently increased minute ventilation to maintain a normal Pco2 owing to the increased work of breathing and marked ventilation-perfusion mismatch. The level of hypercapnia is related in general to the degree of obstruction, although lung mechanics, resting respiratory drive, and the pattern of breathing are often similar in patients with and without C02 retention . Development of hypercapnia depends on poorly understood interactions of inherited respiratory drive, peripheral sensory receptor stimulation, associated hypoxemia, degree of ventilation-perfusion mismatching, and the metabolic milieu.
Asthma. Patients with acute asthma display hyperventilation and hypocapnia, presumably due to stimulation of lung sensory receptors. C02 retention is a late finding in the progression of a severe asthmatic attack. Indeed, eucapnia, rather than the expected hypocapnia, is a warning sign of impending deterioration.
Other disorders in which abnormal peripheral sensory receptor stimulation is thought to result in an increased respiratory drive with resultant dyspnea, tachypnea, and hypocapnia include restrictive lung disease, pulmonary vascular disease, and abnormalities of the chest wall.
Central Hypoventilation. This may occur secondary to brain stem involvement by tumor, ischemia, or inflammatory disease; a primary, idiopathic form has also been described. Patients display decreased chemosensitivity, often with resting hypercapnia and cor pulmonale. Rarely the impairment of chemosensitivity may be so severe that the patient breathes adequately only when stimulated by wakefulness but hypoventi-lates and becomes apneic during sleep, when rostral neural influences are removed.
Obesity-Hypoventilation Syndrome. Some patients with obesity display chronic hypoventilation with hypoxia, hypercapnia, reduced chemosensitivity, and cor pulmonale. The hypoventilation may partly reflect the response to the increased load of fatty tissue on the chest wall, although hypoventilation is not directly related to the degree of obesity. Independent neural factors, yet undefined, are probably important. A subgroup called pickwickian have obesity, daytime hypoventilation, hypersomnolence, polycythemia, and cor pulmonale. All patients with the pickwickian syndrome probably have sleep apnea.
Breathing Pattern Abnormalities Associated with neurological Disease. Central neurogenic hyperventilation has been considered a characteristic feature of lower brain stem and upper pontine disease. Rarely is it an isolated finding, as most patients display associated pulmonary complications that could reflexly stimulate the respiratory center through hypoxia or activation of intrapulmonary sensory receptors. Apneustic breathing consists of sustained inspiratory pauses, localizing damage to the mid pons, most commonly due to a basilar artery infarct. Biot’s or ataxic breathing, a haphazard random distribution of deep and shallow breaths, is caused by disruption of the respiratory rhythm generator in the medulla.
Cheyne-Stokes respiration is characterized by regular cycles of crescendo-decrescendo changes in tidal volume separated by apneic or hypopneic pauses. Many affected patients have evidence of cardiac or neurological disease. In patients with cardiac disease the disturbance arises because of prolongation of the circulation time, which delays transmission of information concerning arterial Po2 and Pco2 to the respiratory centers, thus leading to system instability with resulting oscillations in tidal volume. It has no localizing value in patients with neurological disease but has generally been considered to be an ominous sign. While this is sometimes the case, many patients display subtle evidence of Cheyne-Stokes respiration, especially during sleep, without serious consequences, and it is not an uncommon finding in otherwise normal elderly subjects.
Neuromuscular Disease. Respiratory center function is poorly defined in neuromuscular disease. Decreased ventilatory capacity may result from impaired neural output or poor translation of this neural output into respiratory muscle contraction. Typically, the patients display an increased respiratory rate and inability to take deep breaths, with consequent susceptibility to atelectasis. Paradoxical motion of the rib cage and abdomen is commonly observed. Typical causes include inflammatory polyneuropathy, amyotrophic lateral sclerosis, myasthenia gravis, and poliomyelitis. The features of diaphragmatic paralysis are discussed in Chapter 26.
- CLINICAL APPROACH TO LIVER DISEASE
- NONOBSTRUCTIVE CAUSES OF ISCHEMIC HEART DISEASE
- CHROMC BROriCMITIS
- Management
- PRE-EXCITATIOIi SYNDROMES
- Public health and environment
- Outcome and Prognosis
- PERIPHERAL ANEURYSMS AMD FISTULAE
- Nephrotic Glomerulopathies
- PLEURAL EFFUSIONS
- Nephrogenic Diabetes Insipidus (NDI)
- MECHANISMS OF ARRHYTHMOGENESIS
- Clinical Course, Pathogenesis, and Anatomy of Acute Tubular Necrosis
- PERICARDIAL DISEASES - ACUTE PERICARDITIS
- CHEST WALL DISEASE
- Neurologic Manifestations
- RESPIRATORY SENSORS
- ACID-PEPTIC DISEASE
- SPECIFIC CLINICAL DISORDERS
- OTHER THERAPEUTIC MODALITIES
- Lidocaine
- SPECIFIC MANIFESTATIONS OF RENAL DISEASE
- PATHOPHYSIOLOGY
- SPECIFIC ARRHYTHMIAS - sinus nodal rhythm disturbances
- EMPHYSEMA
- Clinical Presentation
- DEFINITION
- GROSS ANATOMY
- ENVIRONMENTAL DAMAGE OF THE EXTREMITIES
- C. MALABSORPTION
- The Use of Diuretics
- THE COMMON CLINICAL MANIFESTATIONS OF GASTROINTESTINAL DISEASE
- MYOCARDIAL METABOLISM
- RENAL METABOLISM Of DRUGS
- Regulation of Fluids and Electrolytes